Myopia is a refractive error where distant objects are not clearly seen and appear blurred. Goal of this study was to evaluate long-term effectiveness of Repeated Low-Level Red Light (RLRL) therapy for children with myopia, which primarily focused on Axial length (AL) and Spherical Equivalent Refraction (SER) as primary endpoints.
Methods
The research compared outcomes between RLRL treatment with Single Vision Spectacles (SVS) for childhood myopia management. We performed a systematic literature search in the PubMed, Embase and Cochrane databases using “Myopia” and “ Repeated Low-Level Red Light “. Mean differences (MD) were estimated and the effects of therapies measured. Publication bias and heterogeneity analysis were carried out by Inverted Precision Effect Test-Precision Effect Estimate Standard Error (PET-PEESE) (and subsequent Search Sequential Analysis) and Tau test. Bayesian meta-analysis was performed using Jaffrey Amazing Statistical Package (JASP).
Results
This meta-analysis comprised 1,714 participants: 824 in RLRL and 890 in SVS group. Pooled effect size for AL reduction was 0.953 ± 0.294, (95% credible interval (CI) 0.775 to 0.980). Pooled effect size for SER reduction was 1.521 ± 0.662 (95% CI 0.102 to 2.736). PET-PEESE analysis revealed no significant publication bias (p-value 0.407). Random effects models were employed for presence of significant heterogeneity (3.9 and 5.7 for AL; 5.7 for SER), alongside degree of variation (0.828 & 1.665) for Tau (τ), which estimates the between-study variance.
Conclusion
Long-term observations indicate that RLRL treatment significantly influences myopia management, leading to considerable reductions in both AL and SER. Additional research is essential to investigate potential long-term rebound effects.
FlaxmanSRBourneRRAResnikoffS, et al.Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health2017; 5: e1221–e1234. doi:https://doi.org/10.1016/S2214-109X(17)30393-5
HoldenBAFrickeTRWilsonDA, et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology2016; 123: 1036–1042. doi:https://doi.org/10.1016/j.ophtha.2016.01.006
4.
JonasJBAngMChoP, et al.IMI Prevention of myopia and its progression. Invest Ophthalmol Vis Sci2021; 62: 6. doi:https://doi.org/10.1167/iovs.62.5.6
HuYDingXGuoX, et al.Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. JAMA Ophthalmol2020; 138: 1129–1134. doi:https://doi.org/10.1001/jamaophthalmol.2020.3451
10.
PärssinenOKauppinenM. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol (Copenh)2019; 97: 510–518. doi:https://doi.org/10.1111/aos.13964
HaarmanAEEnthovenCATidemanJWL, et al.The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci2020; 61: 49–49. doi:https://doi.org/10.1167/iovs.61.4.49
13.
XiongSSankaridurgPNaduvilathT, et al.Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol (Copenh)2017; 95: 551–566. doi:https://doi.org/10.1111/aos.13403
ZhouLXingCQiangW, et al.Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort. Ophthalmic Physiol Opt2022; 42: 335–344. doi:https://doi.org/10.1111/opo.12939
17.
JiangYZhuZTanX, et al.Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology2022; 129: 509–519. doi:https://doi.org/10.1016/j.ophtha.2021.11.023
ChenHWangWLiaoY, et al.Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol2023; 261: 575–584. doi:https://doi.org/10.1007/s00417-022-05794-4
20.
TianLCaoKMaD-L, et al.Investigation of the efficacy and safety of 650 nm low-level red light for myopia control in children: a randomized controlled trial. Ophthalmol Ther2022; 11: 2259–2270. doi:https://doi.org/10.1007/s40123-022-00585-w
21.
PageMJBossuytPM, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J2021; 372: 1–9. https://www.bmj.com/content/372/bmj.n71.short (accessed 26 March 2024).
YoussefMAShehataARAdlyAM, et al.Efficacy of repeated low-level red light (RLRL) therapy on myopia outcomes in children: a systematic review and meta-analysis. BMC Ophthalmol2024; 24: 78. doi:https://doi.org/10.1186/s12886-024-03337-5
24.
WanXWangWLiuJ, et al.Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol2014; 14: 135. doi:https://doi.org/10.1186/1471-2288-14-135
25.
HigginsJPTThomasJChandlerJ, et al. (eds) Cochrane handbook for systematic reviews of interventions. 1st ed. Cochrane Collaboration and John Wiley & Sons Ltd; 2008. Epub ahead of print 23 September 2019. doi:https://doi.org/10.1002/9781119536604
ZhouLTongLLiY, et al.Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence. Sci Rep2023; 13: 3321. doi:https://doi.org/10.1038/s41598-023-30500-7
31.
DongJZhuZXuH, et al.Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial. Ophthalmology2023; 130: 198–204. doi:https://doi.org/10.1016/j.ophtha.2022.08.024
32.
XiongRZhuZJiangY, et al.Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy. Ophthalmology2023; 130: 286–296. doi:https://doi.org/10.1016/j.ophtha.2022.10.002
33.
ZhouWLiaoYWangW, et al.Efficacy of different powers of low-level red light in children for myopia control. Ophthalmology2024; 131: 48–57. doi:https://doi.org/10.1016/j.ophtha.2023.08.020
34.
HeXWangJZhuZ, et al.Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. JAMA Netw Open2023; 6: e239612. doi:https://doi.org/10.1001/jamanetworkopen.2023.9612
35.
WangWJiangYZhuZ, et al.Clinically significant axial shortening in myopic children after repeated low-level red light therapy: a retrospective multicenter analysis. Ophthalmol Ther2023; 12: 999–1011. doi:https://doi.org/10.1007/s40123-022-00644-2
36.
WangWJiangYZhuZ, et al.Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. Ophthalmol Ther2023; 12: 1223–1237. doi:https://doi.org/10.1007/s40123-023-00671-7
37.
LinZ-HTaoZ-YKangZ-F, et al.A study on the effectiveness of 650-nm red-light feeding instruments in the control of myopia. Ophthalmic Res2023; 66: 652–659.
38.
DengBZhouMKongX, et al.A meta-analysis of randomized controlled trials evaluating the effectiveness and safety of the repeated low-level red light therapy in slowing the progression of myopia in children and adolescents. Indian J Ophthalmol2024; 72: S203–S210.
SawS-MMatsumuraSHoangQV. Prevention and management of myopia and myopic pathology. Invest Ophthalmol Vis Sci2019; 60: 488–499. doi:https://doi.org/10.1167/iovs.18-25221
41.
CohenYPelegEBelkinM, et al.Ambient illuminance, retinal dopamine release and refractive development in chicks. Exp Eye Res2012; 103: 33–40. doi:https://doi.org/10.1016/j.exer.2012.08.004
RanaDColombaniTMohammedHS, et al.Strategies to prevent dopamine oxidation and related cytotoxicity using various antioxidants and nitrogenation. Emergent Mater2019; 2: 209–217. doi:https://doi.org/10.1007/s42247-019-00037-5
MéridaSVillarVMNaveaA, et al.Imbalance between oxidative stress and growth factors in human high myopia. Front Physiol2020; 11: 463. doi:https://doi.org/10.3389/fphys.2020.00463
46.
ZhangMZhangRZhaoX, et al.The role of oxidative stress in the pathogenesis of ocular diseases: an overview. Mol Biol Rep2024; 51: 454. doi:https://doi.org/10.1007/s11033-024-09425-5
DaiLYangWQinX, et al.Serum metabolomics profiling and potential biomarkers of myopia using LC-QTOF/MS. Exp Eye Res2019; 186: 107737. doi:https://doi.org/10.1016/j.exer.2019.107737
49.
JówkoEPłaszewskiMCieślińskiM, et al.The effect of low level laser irradiation on oxidative stress, muscle damage and function following neuromuscular electrical stimulation. A double blind, randomised, crossover trial. BMC Sports Sci Med Rehabil2019; 11: 38. doi:https://doi.org/10.1186/s13102-019-0147-3
50.
OjaghiRSohanakiHGhasemiT, et al.Role of low-intensity laser therapy on naloxone-precipitated morphine withdrawal signs in mice: is nitric oxide a possible candidate mediator?Lasers Med Sci2014; 29: 1655–1659. doi:https://doi.org/10.1007/s10103-014-1530-7
51.
RubisLM. Chiropractic management of Bell palsy with low level laser and manipulation: a case report. J Chiropr Med2013; 12: 288–291. doi:https://doi.org/10.1016/j.jcm.2013.10.001
52.
YamauraMYaoMYaroslavskyI, et al.Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes. Lasers Surg Med2009; 41: 282–290. doi:https://doi.org/10.1002/lsm.20766
53.
ChiouGCYXuanBLiuQ, et al.Inhibition of interleukin-1-induced uveitis and corneal fibroblast proliferation by interleukin-1 blockers. J Ocul Pharmacol Ther2000; 16: 407–418. doi:https://doi.org/10.1089/jop.2000.16.407
XueMLiBLuY, et al.FOXM1 Participates in scleral remodeling in myopia by upregulating APOA1 expression through METTL3/YTHDF2. Invest Ophthalmol Vis Sci2024; 65: 19. doi:https://doi.org/10.1167/iovs.65.1.19
56.
QuJ. A new finding in myopia research (II): sclera hypoxia may be implicated in myopia. In: Progress in myopia prevention and control. Singapore: Springer Nature Singapore, 2024, pp.63–66.
57.
MichaudLVincentS. Scleral lenses and hypoxia: a balanced approach. Contact Lens Spectr2019; 34: 40–42.
58.
ZhangPZhuH. Light signaling and myopia development: a review. Ophthalmol Ther.2022; 11: 939–957.2022 doi:https://doi.org/10.1007/S40123-022-00490-2. Epub ahead of print.
59.
SchillingTTorresCCWongN, et al.Selective stimulation of the optic nerve head with blue light increases vitreal dopamine levels in rabbits. Invest Ophthalmol Vis Sci2021; 62: 1385–1385.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
